L535 (Aspirin Delayed Release 81 mg)
Pill imprint L535 has been identified as Aspirin delayed release 81 mg.
Aspirin is used in the treatment of angina; pain; angina pectoris prophylaxis; ankylosing spondylitis; antiphospholipid syndrome (and more), and belongs to the drug classes platelet aggregation inhibitors, salicylates. FDA has not classified the drug for risk during pregnancy. Aspirin 81 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- L535
- Strength:
- 81 mg
- Color:
- Yellow
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- Platelet aggregation inhibitors
Salicylates - Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Perrigo Company
- National Drug Code (NDC):
- 00113-0535
More about aspirin
Consumer resources
- Aspirin chewable tablets
- Aspirin controlled-release tablets
- Aspirin delayed-release tablets
- Aspirin effervescent tablets
- Aspirin gum
- Aspirin suppositories
- Other brands: Ecotrin, Bayer Aspirin, Aspir 81, Ascriptin, More (16) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
